From Name

From Email

To Name

To Email

Message

SGLT-2 Inhibitors May Raise Risk for Diabetic Ketoacidosis

from Medical Xpress

SGLT-2 Inhibitors May Raise Risk for Diabetic Ketoacidosis Medical Xpress In patients with type 2 diabetes, sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with an increased risk for diabetic ketoacidosis (DKA), according to a study published online July 28 in the Annals of Internal Medicine. READ MORE

more